Loading...
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
Immunostimulatory monoclonal antibodies (mAbs) exert antineoplastic effects by eliciting a novel or reinstating a pre-existing antitumor immune response. Most often, immunostimulatory mAbs activate T lymphocytes or natural killer (NK) cells by inhibiting immunosuppressive receptors, such as cytotoxi...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Landes Bioscience
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3961485/ https://ncbi.nlm.nih.gov/pubmed/24701370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27297 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|